CB2 Insights to Host FY2018 Earnings Call on May 1, 2019
April 26, 2019 09:30 ET
|
CB2 Insights
TORONTO, April 26, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be...
CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado
April 10, 2019 07:00 ET
|
CB2 Insights
TORONTO, April 10, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services...
CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity
April 04, 2019 08:39 ET
|
CB2 Insights
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services...
CB2 Insights Signs Agreement with Premier Health to Integrate Medical Cannabis Clinical Decision Support Tool
March 27, 2019 07:00 ET
|
CB2 Insights
TORONTO, March 27, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to...
CB2 Insights Clarifies Terms of Agreement to Acquire MedEval LLC
March 20, 2019 14:33 ET
|
CB2 Insights
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services...
CB2 Insights Signs Agreement to Acquire Medical Cannabis Clinic Group in Colorado and Arizona
March 20, 2019 07:00 ET
|
CB2 Insights
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE: CBII), a leading provider of predictive analytics tools, data-driven software and comprehensive services...